Compounds > febuxostat
Page last updated: 2024-09-04

febuxostat and Drug-Related Side Effects and Adverse Reactions

febuxostat has been researched along with Drug-Related Side Effects and Adverse Reactions in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Asad, A; Batra, S; Ochani, RK; Yasmin, F1
Chang, CJ; Chang, YC; Chen, CB; Chen, CH; Chen, SM; Chen, WT; Chi, CC; Chung, WH; Hsu, LA; Hung, SI; Lin, KM; Lin, YJ; Lu, CW; Pan, RY; Su, SC; Wang, CW; Wu, YJ; Yu, KH1
Chahine, G; Fayad, F; Ghorra, C; Khalife, N; Khoury, N; Saleh, K1
Hussar, DA1

Reviews

1 review(s) available for febuxostat and Drug-Related Side Effects and Adverse Reactions

ArticleYear
Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis.
    Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:2

    Topics: Aged; Allopurinol; Asian People; Cardiovascular Diseases; Cohort Studies; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Febuxostat; Gout; Gout Suppressants; Humans; Middle Aged; Taiwan

2019

Other Studies

4 other study(ies) available for febuxostat and Drug-Related Side Effects and Adverse Reactions

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
A word of caution regarding Febuxostat.
    JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69, Issue:12

    Topics: Allopurinol; Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Febuxostat; Gout Suppressants; Humans; Hyperuricemia; Pakistan; Xanthine Oxidase

2019
Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.
    Joint bone spine, 2017, Volume: 84, Issue:2

    Topics: Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Febuxostat; Gout Suppressants; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Polymyositis; Rhabdomyolysis; Tumor Lysis Syndrome

2017
New Drugs2010, PART 1.
    Nursing, 2010, Volume: 40, Issue:2

    Topics: Acetamides; Antibodies, Monoclonal; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Azepines; Benzazepines; Benzhydryl Compounds; Benzyl Alcohol; Benzylamines; Cyclams; Cyclopropanes; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Everolimus; Febuxostat; Fluorenes; Fluoroquinolones; Gout Suppressants; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Indoles; Lacosamide; Milnacipran; Oligopeptides; Phenols; Selective Serotonin Reuptake Inhibitors; Sirolimus; Tapentadol; Thiazoles; Tolvaptan; Triazoles

2010